VIORGON 20 - bioregulator-phytocomposition against metabolic disorders

VIOGRON 20 is a bioregulator-phytocomposition against metabolic disorders, in particular gout.

Composition: 1 ml of sterile solution contains: demineralized water, 0.1±0.01 mg CaCI₂ and protein-peptide complex concentrate from: ledum, birch, lingonberry, melon, watermelon, cabbage, dandelion, linden, tansy, horsetail, horseradish, garlic, St. John's wort, hellebore.

The physiological effect of Viorgon-20 is associated with the properties of medicinal plants included in its composition, its ability to additionally activate cellular sources of metabolism, removing uric acid from the body.

Recommendations for use: for the prevention of gout and metabolic disorders.

How to use: 20-30 minutes before a meal, 5-10 drops of the solution are dripped under the tongue, washed down with a small amount of water. Take 2 times a day, if necessary up to 3-5 times a day. The course of admission is 1-2 months.

Contraindications: not found.

Overdose: excluded.

Habituation effect: none.

Storage conditions: in a clean, dry, sun-protected place at a temperature of +5 to +25 ° C and a relative humidity of not more than 75%.

Shelf life: 2 years from the date of manufacture. Once opened, use within 60 days.

Release form: 30 ml (~600 drops).

Guaranteed authenticity and quality:

100% Original from AURORA and Institute for Problems of Bioregulation Ltd. (Russian Federation)

AURORA company is dedicated to cutting-edge, innovative research and methods in the healthcare sector. Aurora's main goals: promotion and popularization of a healthy lifestyle; providing the world with modern discoveries of Russian science related to providing every inhabitant of theplanet with a natural, healthy diet; creating conditions for a healthy internal environment.

Development and production:

AURORA, Institute for Problems of Bioregulation Ltd. and IPB LLC, Moscow (Russian Federation)

The IPB company conducts research and development, collaborating with various Russian Academy of Sciences institutes and medical organizations. To date, we have published over 250 scientific papers and received over 10 patents for the study of protein-peptide bioregulators. The Institute produces 4 lines of protein-peptide complexes of the highest quality, comprising 65 items.

Viorgons are protein-peptide drink complexes containing bioregulators (MGTBio) of animal, plant, and fungal origin in low concentrations. Used for oral administration.